Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (F-CREATE project).
Toshiki MaedaTakumi NishiShunsuke FunakoshiKazuhiro TadaMasayoshi TsujiAtsushi SatohMiki KawazoeChikara YoshimuraHisatomi ArimaPublished in: Heart (British Cardiac Society) (2020)
Among patients with atrial fibrillation on anticoagulant therapy, approximately one-third of the residual risks were estimated to be attributable to modifiable risk factors such as hypertension, diabetes and dyslipidaemia.
Keyphrases
- atrial fibrillation
- risk factors
- human health
- oral anticoagulants
- left atrial
- catheter ablation
- direct oral anticoagulants
- blood pressure
- venous thromboembolism
- left atrial appendage
- type diabetes
- cardiovascular disease
- heart failure
- risk assessment
- quality improvement
- glycemic control
- percutaneous coronary intervention
- big data
- climate change
- adipose tissue
- left ventricular
- coronary artery disease
- acute coronary syndrome
- data analysis
- mesenchymal stem cells